pdufa.bio

Ampligen

Page updated ·next FDA decision on the calendar ·Data as of Oct 13, 2026 11:39 PM ET

Ampligen is an AIM ImmunoTech Inc. program. Its next catalyst is a Readout in Apr 2027. Every date links its source.

AIM catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: AIM ImmunoTech Inc. (AIM). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Apr 2027AIM

Questions

When is Ampligen's next FDA decision or readout?

The next tracked catalyst for Ampligen is a Readout in Apr 2027.

What happened at Ampligen's most recent FDA decision?

No FDA decision for Ampligen is in our archive yet.

Who makes Ampligen?

AIM ImmunoTech Inc. (AIM).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.